{"id":847,"date":"2020-02-05T14:41:48","date_gmt":"2020-02-05T13:41:48","guid":{"rendered":"https:\/\/pharmavalue.it\/?p=847"},"modified":"2021-04-02T12:38:27","modified_gmt":"2021-04-02T10:38:27","slug":"the-words-in-the-new-decree-on-negotiation-criteria","status":"publish","type":"post","link":"https:\/\/pharmavalue.it\/en\/the-words-in-the-new-decree-on-negotiation-criteria\/","title":{"rendered":"The Words in the New Decree on Negotiating Criteria"},"content":{"rendered":"<p>Many in the sector have analysed the Interministerial Decree on the new negotiation criteria published in the Official Journal on 24 July 2020, making the necessary comparisons with CIPE Resolution 3\/2001.<br \/>\nWe at Pharma Value have tried to change our perspective, attempting to understand from an analysis of the frequency of use of certain words, the orientations of the new decree. What jumps out at us, however, are not the words that are most present, but those that are missing. What I do not mention - in fact - does not exist.<br \/>\nThe word benefit appears only once, but in reference to the lack of it;<br \/>\nWords concerning the semantic field of innovation appear only once, but in reference to negotiating models and not to drugs.<br \/>\nWe NEVER talk about sustainability, innovation, incremental innovation and the clinical benefits of a drug. What do you think?<\/p>","protected":false},"excerpt":{"rendered":"<p>In molti del settore hanno analizzato il decreto interministeriale sui nuovi criteri negoziali pubblicato in Gazzetta ufficiale il 24 luglio 2020, facendo i dovuti confronti con la delibera CIPE 3\/2001. Noi di Pharma Value abbiamo provato a cambiare prospettiva, provando a capire dall\u2019analisi delle frequenze di utilizzo di alcune parole, gli orientamenti del nuovo decreto. [&hellip;]<\/p>\n","protected":false},"author":314,"featured_media":851,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"9","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":""},"categories":[9],"tags":[14,16,15,18,17],"class_list":["post-847","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-appunti","tag-appuntidipharmavalue","tag-beneficio","tag-criteri-negoziali","tag-innovazione","tag-sostenibilita"],"_links":{"self":[{"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/posts\/847","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/users\/314"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/comments?post=847"}],"version-history":[{"count":0,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/posts\/847\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/media\/851"}],"wp:attachment":[{"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/media?parent=847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/categories?post=847"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/tags?post=847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}